These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 875465)

  • 1. Physiologic mechanisms of bupicomide- and hydralazine-induced increase in plasma renin activity in hypertensive patients.
    Velasco M; McNay JL
    Mayo Clin Proc; 1977 Jul; 52(7):430-2. PubMed ID: 875465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: a comparison with hydralazine.
    Velasco M; Gilbert CA; Rutledge CO; McNay JL
    Clin Pharmacol Ther; 1975 Aug; 18(2):145-53. PubMed ID: 1097150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity.
    O'Malley K; Velasco M; Wells J; McNay JL
    J Clin Invest; 1975 Feb; 55(2):230-5. PubMed ID: 1127099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observation on the mechanism of renin release by hydralazine in hypertensive patients.
    Ueda H; Kaneko Y; Takeda T; Ikeda T; Yagi S
    Circ Res; 1970 Oct; 27():Suppl 2:201-6. PubMed ID: 4918551
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic and renal hemodynamic effects of bupicomide: a new vasodilator.
    Chrysant SG; Adamopoulos P; Tsuchiya M; Frohlich ED
    Am Heart J; 1976 Sep; 92(3):335-9. PubMed ID: 782220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydralazine and oxprenolol in the treatment of hypertension and the effect of these drugs on plasma renin activity.
    Siitonen L
    J Int Med Res; 1980; 8(3):181-7. PubMed ID: 6993250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK; Dubinion JH; Mi Z
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of antihypertensive, renal hemodynamic, and humoral effects of pinacidil and hydralazine monotherapy.
    Abraham PA; Halstenson CE; Matzke GR; Keane WF
    J Clin Hypertens; 1987 Dec; 3(4):439-51. PubMed ID: 3330986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydralazine and plasma renin activity.
    Ueda H; Yagi S; Kaneko Y
    Arch Intern Med; 1968 Nov; 122(5):387-91. PubMed ID: 5687924
    [No Abstract]   [Full Text] [Related]  

  • 10. Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in rats.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1684-90. PubMed ID: 3064752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group.
    Francis GS; Cohn JN; Johnson G; Rector TS; Goldman S; Simon A
    Circulation; 1993 Jun; 87(6 Suppl):VI40-8. PubMed ID: 8500238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential blockade of alpha-adrenoceptors by indoramin.
    Nicholls DP; O'Connor PC; Harron DW; Leahey WJ; Shanks RG
    Br J Clin Pharmacol; 1984 Jun; 17(6):719-28. PubMed ID: 6146328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of renal prostaglandins in sympathetically mediated renin relase in the rat.
    Campbell WB; Graham RM; Jackson EK
    J Clin Invest; 1979 Aug; 64(2):448-56. PubMed ID: 37256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
    Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and endocrine changes associated with hypotensive action of amosulalol in essential hypertension.
    Ando K; Noda H; Ogata E; Fujita T
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):7-10. PubMed ID: 1383633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sympathetic responsiveness and antihypertensive effect of beta-receptor blockade in essential hypertension: the effect of atenolol (author's transl)].
    Philipp T; Cordes U; Distler A
    Dtsch Med Wochenschr; 1977 Apr; 102(15):569-74. PubMed ID: 14816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effects of hydralazine and alpha- or beta-adrenergic blockers: the role of plasma renin activity.
    Gutkin M; Das B; Chin BK; Mezey K; Modlinger RS
    J Clin Pharmacol; 1977; 17(8-9):509-18. PubMed ID: 893737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Felodipine, a new vasodilating drug: blood pressure, cardiac, renal, and humoral effects in hypertensive patients.
    Leonetti G; Gradnik R; Terzoli L; Fruscio M; Rupoli L; Zanchetti A
    J Cardiovasc Pharmacol; 1984; 6(3):392-8. PubMed ID: 6202963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators.
    Krum H; Viskoper RJ; Lacourciere Y; Budde M; Charlon V
    N Engl J Med; 1998 Mar; 338(12):784-90. PubMed ID: 9504938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin reduces sympathetic activity in men with hypertension and hypercholesterolemia.
    Lewandowski J; Siński M; Bidiuk J; Abramczyk P; Dobosiewicz A; Ciarka A; Gaciong Z
    Hypertens Res; 2010 Oct; 33(10):1038-43. PubMed ID: 20668455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.